US Broker Ratings

Intuitive Surgical, Inc. (ISRG) Stock Report: Analyzing the 33.93% Potential Upside with Strong Buy Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable player in the medical instruments and supplies industry, with a market capitalization of $149.48 billion. Based in Sunnyvale, California, Intuitive Surgical..

Globus Medical, Inc. (GMED) Stock Analysis: A 37.5% Potential Upside Captures Investor Attention

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, stands out with its robust market presence and promising growth prospects. With a market..

GSK plc (GSK) Stock Analysis: Evaluating a Strong 12.46% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth outlook. With a market capitalization of..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 36.60% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) is capturing investor attention in the healthcare sector with its ambitious approach to drug development and a significant potential upside of 36.60%. As a clinical-stage..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Promising Biotechnology Leader with 47% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, known for its pioneering work in ribonucleic acid interference (RNAi) therapeutics. With a market capitalization of..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential with a 3.15% Upside

Novartis AG (NYSE: NVS), a Swiss pharmaceutical giant, commands a formidable presence in the healthcare sector, specifically within the drug manufacturing industry. As one of the leading players in the..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 35% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector as a formidable player in the medical care facilities industry, boasting a market capitalization of $10.32 billion. Investors are..

Repligen Corporation (RGEN) Stock Analysis: Unlocking a 43.98% Upside in Bioprocessing Innovation

Investors with a keen interest in the healthcare sector’s innovative frontier may find Repligen Corporation (NASDAQ: RGEN) a compelling prospect. With a market capitalization of $6.9 billion, Repligen stands as..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 12.34% Potential Upside Amid Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector, particularly in the drug manufacturing industry, is capturing investor attention with a compelling potential upside of 12.34%. With a market..

Natera, Inc. (NTRA) Stock Analysis: Insights into a High-Growth Diagnostics Leader with a 20% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research sector, is drawing investor attention with its innovative molecular testing services and strong revenue growth. With a market..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Exploring a 39% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing the attention of investors with its focus on groundbreaking therapies for metabolic dysfunction-associated steatohepatitis (MASH). With..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 19.89% Potential Upside

Investors eyeing opportunities in the healthcare sector may find Becton, Dickinson and Company (NYSE: BDX) a compelling option. With a robust market cap of $41.65 billion, BDX stands as a..

Agilent Technologies, Inc. (A) Stock Analysis: Healthcare Giant with 18.87% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, is renowned for its innovative solutions in the diagnostics and research industry. With a market capitalization of $38.25..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 23.79% Upside Potential with Strong Buy Ratings

IQVIA Holdings, Inc. (NYSE: IQV), a powerhouse in the diagnostics and research industry, stands as a key player in the healthcare sector. With a market capitalization of $30.62 billion, this..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and a 19% Potential Upside

Investors are paying close attention to Cardinal Health, Inc. (NYSE: CAH) as the company stands out in the healthcare sector with promising growth metrics and a favorable analyst outlook. With..

Novo Nordisk A/S (NVO) Stock Analysis: Tackling Diabetes and Obesity with a 9.07% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a kingpin in the healthcare sector, remains a formidable player in the global drug manufacturing industry. Headquartered in Bagsvaerd, Denmark, the company is a juggernaut..

BioNTech SE (BNTX) Stock Analysis: Unpacking a 39% Potential Upside Amidst Challenging Metrics

BioNTech SE (NASDAQ: BNTX) stands as a prominent player in the biotechnology sector, with its roots deeply embedded in the healthcare landscape of Germany. Renowned for its groundbreaking mRNA vaccine,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 29% Potential Upside Amid Robust Growth

The Ensign Group, Inc. (NASDAQ: ENSG) has positioned itself as a formidable player in the healthcare sector, specializing in medical care facilities. With a market capitalization of $9.95 billion, this..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 54.74% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a key player in the biotechnology sector, is gaining traction among investors due to its innovative approach to treating rare diseases. Based in San Rafael,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds